Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
accession | Q64281 |
express system | HEK293 |
product tag | C-His |
purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
background | LILRB4, also known as CD85k and LIR-5, ILT3, is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. |
molecular weight | The protein has a predicted MW of 25.1 kDa. Due to glycosylation, the protein migrates to 30-45 kDa based on Tris-Bis PAGE result. |
available size | 100 µg, 500 µg |
endotoxin | Less than 1EU per μg by the LAL method. |
Mouse LILRB4/CD85k/ILT3 Protein 3953
$300.00 – $1,000.00
Summary
- Expression: HEK293
- Binding assay: Yes (SPR)
- Amino Acid Range: Gly24-Lys238
Mouse LILRB4/CD85k/ILT3 Protein 3953
protein |
---|
Size and concentration 100, 500µg and lyophilized |
Form Lyophilized |
Storage Instructions Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Storage buffer Shipped at ambient temperature. |
Purity > 95% as determined by Tris-Bis PAGE |
target relevance |
---|
LILRB4,also known as CD85k and LIR-5, ILT3, is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. |
Protein names Leukocyte immunoglobulin-like receptor subfamily B member 4A (Mast cell surface glycoprotein Gp49B) (CD antigen CD85k) |
Gene names Lilrb4a,Lilrb4a Gp49b |
Mass 10090Da |
Function Inhibitory receptor involved in the down-regulation of the immune response (PubMed:10026201, PubMed:24935931). Receptor for FN1 (PubMed:34089617). Receptor for integrin ITGAV/ITGB3 (PubMed:11323698). Inhibits IgE-mediated mast cell activation, at least in part through interaction with ITGAV/ITGB3 (PubMed:10026201, PubMed:11323698, PubMed:11457897, PubMed:8855262). Also inhibits KITLG/SCF-mediated mast cell activation (PubMed:12884301). Through interaction with ITGAV/ITGB3, inhibits antibody production by memory and marginal zone B cells, probably by suppressing their differentiation into plasma cells (PubMed:24935931). Inhibits IFNG production by CD8 T cells, CD4 T cells and natural killer cells (PubMed:12682239). Inhibits antigen presentation by dendritic cells to T cells, preventing T cell activation (PubMed:18792399). Inhibits lipopolysaccharide-mediated neutrophil-dependent vascular injury (PubMed:14557414). Suppresses the allergic inflammatory response by inhibiting infiltration of neutrophils and eosinophils and preventing mast cell degranulation (PubMed:17761953). Inhibits lysis by natural killer cells (PubMed:8977169). |
Subellular location Cell membrane ; Single-pass type I membrane protein . |
Tissues Expressed on mast cells and natural killer cells (at protein level) (PubMed:11457897, PubMed:8977169, PubMed:8977170). Expressed on neutrophils (at protein level) (PubMed:14557414). Expressed on eosinophils (at protein level) (PubMed:17761953). Expressed on dendritic cells (at protein level) (PubMed:18792399). Expressed on memory and marginal zone B cells (at protein level) (PubMed:24935931). Expressed on CD8 T cells (at protein level) (PubMed:12682239). Expressed in the uterus of pregnant mice where it is detected at day 4.0 of pregnancy with levels dropping at day 4.5 (PubMed:9338594). Highly expressed in the luminal epithelium of uterine endometrium with lower levels in the glandular epithelium (PubMed:9338594). |
Structure Interacts (when tyrosine phosphorylated) with SH2 domain-containing phosphatases PTPN6/SHP-1 and PTPN11/SHP-2; interaction with PTPN6 enhances inhibition of mast cell activation. |
Post-translational modification Tyrosine phosphorylated. |
Domain Co |
Target Relevance information above includes information from UniProt accession: Q64281 |
The UniProt Consortium |
Publications
pmid | title | authors | citation |
---|---|---|---|
We haven't added any publications to our database yet. |
relevant to this product |
---|
# | ||
---|---|---|
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.